skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Arterial Hepatic Embolization of Unresectable Hepatocellular Carcinoma Using a Cyanoacrylate/Lipiodol Mixture

Journal Article · · Cardiovascular and Interventional Radiology
DOI:https://doi.org/10.1007/S002709900247· OSTI ID:21080410
 [1];  [2];  [3]; ;  [1];  [3];  [2];  [1]
  1. Department of Internal Medicine I, Clinical Division of Oncology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna (Austria)
  2. Department of Internal Medicine IV, Clinical Division of Gastroenterology and Hepatology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna (Austria)
  3. Department of Radiology, Clinical Division of Interventional Radiology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna (Austria)

Purpose: A survival analysis in 16 patients with unresectable hepatocellular carcinoma (HCC) undergoing transcatheter arterial embolization (TAE) using a combination of lipiodol and N-butyl-2-cyanoacrylate (5 : 1) was performed in a retrospective study. Methods: A combination of lipiodol and N-butyl-2-cyanoacrylate (5 : 1) was used for TAE. All patients had disease compatible with Okuda stages I and II. Results: Twenty-four embolizations were done; five patients had more than one embolization. Median alpha-fetoprotein levels declined from 116 to 48.6 ng/ml. A median of 0.3 ml cyanoacrylate was administered per patient. Median survival was 8.5 months (range 2-49 months). After a median follow-up of 4 years, 12 patients have died (75%). Okuda stage I and II patients had a median survival time of 34.4 and 5.5 months respectively. Few side effects (19%) were seen. Conclusion: We conclude that the TAE procedure used [lipiodol and N-butyl-2-cyanoacrylate (5 : 1)] is safe and produced only few side effects, thus constituting a valuable therapeutic option for patients with Okuda stage I andII HCC.

OSTI ID:
21080410
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 21, Issue 3; Other Information: DOI: 10.1007/s002709900247; Copyright (c) 1996 Springer-Verlag New York Inc; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English